Booth Andrew bought ABCL

November 13, 2026 · Form 4 insider transaction

Booth Andrew bought 8,600 shares of AbCellera Biologics Inc. at $11.33 per share, a transaction worth $97.4K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 0 days after the transaction.